Abstract
The mechanisms underlying the inhibition of bile acid-induced apoptosis by cyclic AMP (cAMP) were studied in 24-h-cultured rat hepatocytes. Taurolithocholate 3-sulfate (TLCS, 100 micromol/l) led to a sustained activation of mitogen activated protein (MAP) kinases (JNK, p38(MAPK), and ERKs), dephosphorylation of protein kinase B (PKB), activation of caspases 3 and 8, and hepatocyte apoptosis. cAMP prevented TLCS-induced apoptosis, shifted the persistent TLCS-induced MAP kinase response to a transient pattern, and prevented PKB dephosphorylation. TLCS-induced CD95 and TRAIL receptor-2 trafficking to the plasma membrane were significantly inhibited. Blockade of protein kinase A (PKA) abolished the inhibitory effect of cAMP on TLCS-induced CD95 membrane targeting, but not TRAIL receptor-2 membrane targeting, PKB and MAP kinase responses. H89, an inhibitor of PKA, had no effect on cAMP-induced inhibition of TLCS-triggered poly(ADP) ribose polymerase (PARP) cleavage and caspase activation, but abolished the cAMP-induced inhibition of TLCS-triggered TUNEL- and Annexin V staining. It is concluded that cAMP inhibits bile acid-induced apoptosis via PKA-dependent and -independent mechanisms.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis / drug effects*
-
Bile Acids and Salts / biosynthesis
-
Caspase 3
-
Caspase 8
-
Caspase 9
-
Caspases / biosynthesis
-
Caspases / drug effects
-
Cells, Cultured
-
Cyclic AMP / pharmacology*
-
Cyclic AMP-Dependent Protein Kinases
-
Hepatocytes / cytology
-
Hepatocytes / drug effects*
-
Hepatocytes / metabolism*
-
Male
-
Mitogen-Activated Protein Kinase Kinases / biosynthesis
-
Mitogen-Activated Protein Kinase Kinases / drug effects
-
Protein Serine-Threonine Kinases*
-
Proto-Oncogene Proteins / biosynthesis
-
Proto-Oncogene Proteins / drug effects
-
Proto-Oncogene Proteins c-akt
-
Rats
-
Rats, Wistar
-
Receptors, TNF-Related Apoptosis-Inducing Ligand
-
Receptors, Tumor Necrosis Factor / biosynthesis
-
Receptors, Tumor Necrosis Factor / drug effects
-
Reference Values
-
Reproducibility of Results
-
Sensitivity and Specificity
-
Taurolithocholic Acid / analogs & derivatives*
-
Taurolithocholic Acid / pharmacology*
-
fas Receptor / metabolism
Substances
-
Bile Acids and Salts
-
Proto-Oncogene Proteins
-
Receptors, TNF-Related Apoptosis-Inducing Ligand
-
Receptors, Tumor Necrosis Factor
-
Tnfrsf10b protein, rat
-
fas Receptor
-
taurolithocholic acid 3-sulfate
-
Taurolithocholic Acid
-
Cyclic AMP
-
Protein Serine-Threonine Kinases
-
Proto-Oncogene Proteins c-akt
-
Cyclic AMP-Dependent Protein Kinases
-
Mitogen-Activated Protein Kinase Kinases
-
Casp3 protein, rat
-
Casp8 protein, rat
-
Casp9 protein, rat
-
Caspase 3
-
Caspase 8
-
Caspase 9
-
Caspases